The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...

Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd ...

The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of ...

Officials said these will significantly enhance outreach to rural and underserved communities that face some of the highest ...

Never-smokers exposed to high levels of fine particulate air pollution have a significantly greater risk of developing lung ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan ...

Dean Comstock was 27 when he received the frightening diagnosis of terminal lung cancer. The singer and runner had never ...

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, ...